Literature DB >> 758861

Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer.

S Fujimoto, U Kitsukawa, K Itoh.   

Abstract

Carcinoembryonic antigen (CEA) levels in the feces and serum were evaluated in 22 colorectal cancer patients and 20 healthy volunteers; in CEA levels gastric juice and serum were also evaluated in 28 gastric cancer patients and 14 peptic ulcer patients. Fecal CEA was found in all of 22 colorectal cancer patients as well as in the 20 healthy volunteers. Elevated fecal CEA levels were observed in the colorectal cancer patients, as compared to the healthy volunteers. The feces of 15 of the 22 colorectal cancer patients contained CEA at concentrations higher than the mean value plus twice the standard deviation of the healthy volunteers. The fecal CEA levels did not correlate directly either with Dukes' stage or serum CEA levels. CEA in gastric juice was elevated significantly in 26 of gastric cancer patients, with the exception of two patients with early gastric cancer. On the other hand, serum CEA was elevated in only nine of the 28 gastric cancer patients. These results point out the distinct value of assaying CEA in the feces or gastric juice as an aid in the diagnosis of colorectal or gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758861      PMCID: PMC1396958          DOI: 10.1097/00000658-197901000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Carcinoembryonic antigen-like substance in gastric juice.

Authors:  M Vuento; E Ruoslahti; H Pihko; T Svenberg; T Ihamäki; M Siurala
Journal:  Immunochemistry       Date:  1976-04

2.  Immunohistological localization of carcinoembryonic antigen and nonspecific cross-reacting antigen in gastrointestinal normal and tumoral tissues.

Authors:  P Burtin; S von Kleist; M C Sabine; M King
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

3.  Characterization of a second normal antigen that cross-reacts with CEA.

Authors:  P Burtin; G Chavanel; H Hirsch-Marie
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

4.  Increased carcinoembryonic antigen in heavy cigarette smokers.

Authors:  D P Stevens; I R Mackay
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

5.  Metabolism of human carcinoembryonic antigen in xenogeneic animals.

Authors:  J Shuster; M Silverman; P Gold
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

6.  A tumor-associated antigen in gastric cancer secretions.

Authors:  E Deutsch; C A Apffel; H Mori; J E Walker
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

7.  Carcinoembryonic antigen in faeces.

Authors:  D L Freed; G Taylor
Journal:  Br Med J       Date:  1972-01-08

8.  CEA levels in fluids bathing gastrointestinal tumors.

Authors:  I G Molnar; J P Vandevoorde; G L Gitnick
Journal:  Gastroenterology       Date:  1976-04       Impact factor: 22.682

9.  Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma.

Authors:  E G Elias; E D Holyoke; T M Chu
Journal:  Dis Colon Rectum       Date:  1974 Jan-Feb       Impact factor: 4.585

10.  Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues.

Authors:  G Pusztaszeri; J P Mach
Journal:  Immunochemistry       Date:  1973-03
View more
  9 in total

1.  Identification of carcinoembryonic antigen (CEA) in bile of patients with malignant biliary tract disease.

Authors:  K Konomi; K Nakamura; M Tobimatsu; S Saito; K Toyoda; Y Yasunami
Journal:  Jpn J Surg       Date:  1982

2.  Gastric cancer with synchronous unresectable hepatic metastasis and a positive response to chemotherapy--report of two cases.

Authors:  S Fujimoto; R D Shrestha; J Kasanuki; M Kokubun; N Ichiki; A Miyazaki; M Ohta; K Okui
Journal:  Jpn J Surg       Date:  1987-07

3.  Faecal carcinoembryonic antigen in colorectal cancer patients.

Authors:  R S Stubbs; D M Nadkarni; H A Monsey
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

4.  Further investigations of immunoreactive carcinoembryonic antigen (CEA) in colorectal cancer patients--with particular emphasis on the correlation between immunoreactive CEA levels in tissue, feces and blood.

Authors:  S Fujimoto; Y Kitsukawa
Journal:  Jpn J Surg       Date:  1981-01

5.  Immunoreactive carcinoembryonic antigen in gastric juice in patients with gastric cancer.

Authors:  O Kojima; T Tanioku; N Kitagawa; A Oh; Y Uehara; T Kurimoto; T Majima; E Ikeda; B Nishioka; Y Fujita
Journal:  Jpn J Surg       Date:  1983-07

6.  Urinary organ specific neoantigen. A potentially diagnostic test for colorectal cancer.

Authors:  M Tobi; C E Darmon; P Rozen; N Harpaz; A Fink; B Maliakkal; A Halline; S Mobarhan; Z Bentwich
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

7.  Superiority of fecal carcinoembryonic antigen as diagnosis marker for adenomatous polyposis coli and asymptomatic colorectal cancer.

Authors:  Linfang Li; Wenshen Gu; Xingping Wu; Yufeng Ao; Yiling Song; Xiaohui Li; Qiuyao Zeng
Journal:  Therap Adv Gastroenterol       Date:  2021-12-21       Impact factor: 4.409

8.  Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.

Authors:  Linfang Li; Shan Xing; Miantao Wu; Yufeng Ao; Xin Zheng; Rongzeng Cai; Runkun Han; Jingcong Li; Xiaohui Li; Qiuyao Zeng
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

9.  Detection of increased fecal carcinoembryonic antigen and its characterization as a membrane-bound form in colorectal carcinoma and other gastrointestinal disorders.

Authors:  K Sugano; H Ohkura; S Hirohashi; Y Shimosato; Y Sakurai; S Kodaira; O Abe
Journal:  Jpn J Cancer Res       Date:  1989-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.